Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Búsqueda de socio industrial para participar en un proyecto en la convocatoria Fast Track to Innovation (H2020). Tecnología y equipo de biorresonancia de campo electromagnético de alta frecuencia y baja intensidad para diagnóstico y tratamiento

Resumen

Tipo:
Búsqueda de socios
Referencia:
RDLV20160901001
Publicado:
07/09/2016
Caducidad:
07/09/2017
Resumen:
Una universidad letona busca socios con el fin de presentar una propuesta a la convocatoria Fast Track to Innovation (H2020-FTIPILOT-2016). El objetivo es lanzar al mercado una nueva tecnología médica: un aparato de biorresonancia de campo electromagnético de alta frecuencia y baja intensidad para el diagnóstico, tratamiento y profilaxis de trastornos musculoesqueléticos (dolor, espasmos, convulsión, inflamación). Uno de los socios buscados se encargará de obtener el marcado CE y un segundo socio de promocionar y comercializar la tecnología. La fecha límite de la convocatoria es el 25 de octubre de 2016 y el plazo para presentar expresiones de interés finaliza el 20 de octubre. El proyecto tendrá una duración de 3 años.

Details

Tittle:
Industrial partner search for H2020 Fast Track to Innovation project application - High frequency low intensity electromagnetic field bioresonance diagnostics and therapy equipment and technology
Summary:
A university from Latvia seeks for business partners in a Fast Track to Innovation (H2020-FTIPILOT-2016) project proposal. The project will bring an innovative medical technology (high frequency low intensity electromagnetic field bioresonance apparatus for diagnosis, treatment and prophylaxis of musculoskeletal disorders - pain, spasms, seizure, inflammation) to the market. One of the partners´ sought will assist in obtaining EC marking. The other will promote and commercialize the technology.
Description:
Muscle pain, spasms, seizure and inflammation are frequent medical conditions becoming a problem at all ages and resulting in significant health care costs.
Aim of the project is in the framework of H2020 Fast Track to Innovation Pilot to commercialize apparatus and technology which will tackle the musculoskeletal disorder complications. In the project the R-Y-D institutions will perform final clinical tests of the innovative technology prototype - high frequency low intensity electromagnetic field bioresonance apparatus for treatment and prophylaxis of common human muscle pain, spasms, and seizure symptoms. Duration of the project - 3 years.
Three industry/business partners and two academic/clinical partners will make the consortium. The academic/clinical partners No 1 and No 2 will carry out final clinical tests of the bioresonance therapeutic equipment to prove already existing evidence of clinical effectiveness of the technology. Partner No 1, the coordinator of the project, is university/hospital located in Riga, Latvia. Partner No 2 is a hospital based in Spain. Industrial partner No 3 is from Poland. It is authorized and ready to manufacture the bioresonance apparatuses. The industrial partner sought No 4 will obtain the EC certificate for the technology. The other industrial partner sought No 5 will commercialize the innovative medical technology in EC countries and world-wide.
Terms of the funding programme "Fast Track to Innovation Pilot": minimum 3 partners - maximum 5 partners (all based in the EU and/or in Horizon 2020 associated countries). In a consortium with 3 or 4 partners, at least 2 should be industry, and in a consortium with 5 partners, at least 3 should be industry; alternatively at least 60% the project budget should be allocated to industry (i.e. private for profit entities). EU grant of EUR 1 million to 3 million (70% of funding for industrial partners and 100% of funding for non-profit entities). The project foresees transition from market-mature innovation demonstration to market-maturity and market launch. Deadline for the call - October 25, 2016. Deadline for EoI to join this project - October 10, 2016. Anticipated duration of the project - 3 years.
Advantages and Innovations:
It is non-invasive bio-impedance diagnostic and therapeutic method with regenerative effect in wide range of musculoskeletal disorders, including psycho-emotional and physical stress induced muscle pain, spasms, seizure. The device is compact and portable. It can be easily applied in physical medicine, sports medicine, during military missions, in confined spaces (space ship, submarine) and in other circumstances.
Stage of Development:
Proposal under development
Technical Specification or Expertise Sought:
Expertise and assistance in obtaining the EC certificate and bringing the technology into the market is needed.

Partner sought

Partner Sought:
Type of partner sought: Partner No1 - industry/business partner with technical expertise -Y- experience in getting CE marking in compliance with European Medical Device Directives. Tasks to be performed - obtaining the CE marking for the proposed medical technology. Type of partner sought: Partner No2 - industry/business partner. Tasks to be performed - bringing the CE marked innovative medical technology to the market.
Type of Partnership Considered:
RDR

Client

Type and Size of Client:
University
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
German
Latvian

Dissemination

Programme-call

Evaluation Scheme:
Single-stage submission scheme
Anticipated Project Budget:
2 million EUR
Coordinator Required:
No
Deadline for Call:
25/10/2016
Project Duration:
0
Project title and Acronym:
Innovative non-invasive bioresonance diagnostic and therapeutic technology